Sutro Biopharma (STRO) EBIT Margin (2017 - 2025)
Sutro Biopharma's (STRO) quarterly EBIT Margin came in at 576.5% in Q4 2025, down 13584.0% year-on-year from N/an in Q4 2024, and down 15.31% quarter-over-quarter from 499.94% in Q3 2025.
Sutro Biopharma (STRO) EBIT Margin (2017 - 2025) Analysis & Trends
Sutro Biopharma has disclosed EBIT Margin across 9 years of filings, most recently posting 576.5% for Q4 2025.
- EBIT Margin for Q4 2025 came in at 576.5%, down 13584.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 184.71% (up 25575.0% YoY), and the FY2025 annual result was 154.53%, up 22981.0% from the prior year.
- EBIT Margin came in at 576.5% for Q4 2025 at Sutro Biopharma, down from 499.94% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 37.95% in Q4 2023 to a low of 1202.0% in Q1 2025.
- The 5-year median for EBIT Margin is 370.19% (2021), against an average of 375.84%.
- Across the five-year window, EBIT Margin jumped 60817 bps in 2023 and slumped 76695 bps in 2025, its largest moves.
- Sutro Biopharma's EBIT Margin stood at 328.85% in 2021, then slumped by 73 bps to 570.23% in 2022, then surged by 107 bps to 37.95% in 2023, then tumbled by 1261 bps to 440.66% in 2024, then plunged by 31 bps to 576.5% in 2025.
- The last three EBIT Margin figures came in at 576.5% (Q4 2025), 499.94% (Q3 2025), and 5.25% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sutro Biopharma | 252.04 Mn | 252.04 Mn | - | -576.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -576.50% |
| Sep 30, 2025 | -499.94% |
| Jun 30, 2025 | -5.25% |
| Mar 31, 2025 | -1,202.00% |
| Dec 31, 2024 | -440.66% |
| Sep 30, 2024 | -797.17% |
| Jun 30, 2024 | -273.51% |
| Mar 31, 2024 | -435.05% |
| Dec 31, 2023 | 37.95% |
| Sep 30, 2023 | -260.07% |
| Jun 30, 2023 | -443.52% |
| Mar 31, 2023 | -333.26% |
| Dec 31, 2022 | -570.23% |
| Sep 30, 2022 | -84.34% |
| Jun 30, 2022 | -68.97% |
| Mar 31, 2022 | -663.59% |
| Dec 31, 2021 | -328.85% |
| Sep 30, 2021 | -407.12% |
| Jun 30, 2021 | -34.96% |
| Mar 31, 2021 | -129.67% |